Literature DB >> 32944872

Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.

Cassiana Costa Ferreira Leite1, Flavia Alvim Dutra de Freitas1, Mônica de Cássia Firmida2, Robson Souza Leão1, Rodolpho Mattos Albano3, Elizabeth Andrade Marques4.   

Abstract

The application of next-generation sequencing tools revealed that the cystic fibrosis respiratory tract is a polymicrobial environment. We have characterized the airway bacterial microbiota of five adult patients with cystic fibrosis during a 14-month period by 16S rRNA tag sequencing using the Illumina technology. Microbial diversity, estimated by the Shannon index, varied among patient samples collected throughout the follow-up period. The beta diversity analysis revealed that the composition of the airway microbiota was highly specific for each patient, showing little variation among the samples of each patient analyzed over time. The composition of the bacterial microbiota did not reveal any emerging pathogen predictor of pulmonary disease in cystic fibrosis or of its unfavorable clinical progress, except for unveiling the presence of anaerobic microorganisms, even without any established clinical association. Our results could potentialy help us to translate and develop strategies in response to the pathobiology of this disease, particularly because it represents an innovative approach for CF centers in Brazil.

Entities:  

Keywords:  Airway microbiota; Cystic fibrosis; Next-generation sequencing

Mesh:

Substances:

Year:  2020        PMID: 32944872      PMCID: PMC7688754          DOI: 10.1007/s42770-020-00381-3

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  38 in total

1.  Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.

Authors:  Patrick D Schloss; Sarah L Westcott; Thomas Ryabin; Justine R Hall; Martin Hartmann; Emily B Hollister; Ryan A Lesniewski; Brian B Oakley; Donovan H Parks; Courtney J Robinson; Jason W Sahl; Blaz Stres; Gerhard G Thallinger; David J Van Horn; Carolyn F Weber
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

2.  Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.

Authors:  Franziska Anne Stressmann; Geraint B Rogers; Christopher J van der Gast; Peter Marsh; Louic S Vermeer; Mary P Carroll; Lucas Hoffman; Thomas W V Daniels; Nilesh Patel; Benjamin Forbes; Kenneth Deans Bruce
Journal:  Thorax       Date:  2012-06-15       Impact factor: 9.139

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  New reference values for forced spirometry in white adults in Brazil.

Authors:  Carlos Alberto de Castro Pereira; Taeko Sato; Sílvia Carla Rodrigues
Journal:  J Bras Pneumol       Date:  2007 Jul-Aug       Impact factor: 2.624

5.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

6.  Lung microbiota across age and disease stage in cystic fibrosis.

Authors:  Bryan Coburn; Pauline W Wang; Julio Diaz Caballero; Shawn T Clark; Vijaya Brahma; Sylva Donaldson; Yu Zhang; Anu Surendra; Yunchen Gong; D Elizabeth Tullis; Yvonne C W Yau; Valerie J Waters; David M Hwang; David S Guttman
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

7.  The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation.

Authors:  Lisa A Carmody; Jiangchao Zhao; Linda M Kalikin; William LeBar; Richard H Simon; Arvind Venkataraman; Thomas M Schmidt; Zaid Abdo; Patrick D Schloss; John J LiPuma
Journal:  Microbiome       Date:  2015-04-01       Impact factor: 14.650

Review 8.  Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Authors:  Laura M Filkins; George A O'Toole
Journal:  PLoS Pathog       Date:  2015-12-31       Impact factor: 6.823

9.  Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis.

Authors:  Fiona J Whelan; Alya A Heirali; Laura Rossi; Harvey R Rabin; Michael D Parkins; Michael G Surette
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

10.  Longitudinal development of the airway microbiota in infants with cystic fibrosis.

Authors:  Bushra Ahmed; Michael J Cox; Leah Cuthbertson; Phillip James; William O C Cookson; Jane C Davies; Miriam F Moffatt; Andrew Bush
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.